课题基金 / 基金详情

NATURAL INHIBITOR OF COLONIC CELL DAMAGE

NATURAL INHIBITOR OF COLONIC CELL DAMAGE
结肠细胞损伤的天然抑制剂
批准号:
3181182
负责人:
Martin Lipkin
金额:
$11.0万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-01 至 1988-08-31

项目摘要

项目成果

Martin Lipkin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project studies will be carried out to assess the effect of calcium, an natural constituent of food, on the hyperproliferation and impaired maturation of colonic epithelial cells occurring in the mucosa of individuals with increased susceptibility to colon cancer. Measurements of cell proliferation and differentiation will serve as a rapid assay system to evaluate the utility of oral supplementary calcium in inducing repopulation of the colonic mucosa with normal epithelial cells. Recent findings in rodents have indicated that free unesterified fatty acids and free unconjugated bile acids induce damage of colonic epithelial cells, and that this toxicity can be neutralized by a relatively modest increase in calcium availability in the colon. We have now shown in humans that supplementary dietary calcium inhibits a hyperproliferative response of colonic epithelium occurring in individuals at increased risk for colon cancer. In this project, basic controlled metabolic studies will be carried out on the human subjects to determine levels of calcium and durations of administration needed in the diet for this purpose. Extensive measurements will be made which will include determination of the levels of bile acids and fatty acids present in free form and as calcium soaps under various dosage schedules of calcium, and the degree of repopulation of the colon with normal epithelial cells. These measurements will be further extended to study the levels of calcium required and durations of administration needed for these beneficial effects in a series of diseases characterized by increased susceptibility to colon cancer.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Biological markers of cell proliferation and differentiation in human gastrointestinal diseases.
人类胃肠道疾病细胞增殖和分化的生物标志物。
DOI: 10.1016/s0065-230x(08)60433-9
发表时间: 1988
期刊: Advances in cancer research
影响因子: --
作者: [Lipkin,M, Higgins,P]
通讯作者: Higgins,P
DOI: --
发表时间: 1988
期刊: Progress in clinical and biological research
影响因子: --
作者: [Lipkin,M, Newmark,H]
通讯作者: Newmark,H
Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium.
对补充膳食钙有反应和无反应者的结肠上皮细胞增殖。
DOI: --
发表时间: 1989
期刊: Cancer research
影响因子: 11.2
作者: [Lipkin,M, Friedman,E, Winawer,SJ, Newmark,H]
通讯作者: Newmark,H
MECHANISM BASED SCREENING OF CHEMOPREVENTIVE AGENTS
  • 批准号:
    6096053
  • 项目类别:
  • 资助金额:
    $48.06万
  • 财政年份:
    1999
  • 负责人:
    Martin Lipkin
  • 依托单位:
TELOMERASE IN CELLULAR IMMORTALIZATION
  • 批准号:
    2833737
  • 项目类别:
  • 资助金额:
    $32.23万
  • 财政年份:
    1998
  • 负责人:
    Martin Lipkin
  • 依托单位:
IN VITRO SCREENING OF CHEMOPREVENTIVE AGENTS
  • 批准号:
    2833735
  • 项目类别:
  • 资助金额:
    $41.51万
  • 财政年份:
    1998
  • 负责人:
    Martin Lipkin
  • 依托单位:
INTERMEDIATE BIOMARKERS FOR COLORECTAL CANCER & MELANOMA
  • 批准号:
    6052848
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1998
  • 负责人:
    Martin Lipkin
  • 依托单位:
海外基金